PEAKS De Novo Sequencing
Peaks de novo sequencing is a computational method for deriving protein or peptide amino acid sequences directly from mass spectrometry data without relying on known protein sequence databases. In proteomics research, conventional protein identification approaches primarily rely on database-dependent searches, where experimental peptide mass spectra are matched against pre-existing protein databases. However, this approach is inherently limited when analyzing non-model organisms, novel proteins, antibody sequences, or mutant proteins, as reference databases may not comprehensively represent all protein sequence variations.
By leveraging high-resolution mass spectrometry data, Peaks de novo sequencing enables the direct determination of amino acid sequences, offering an efficient and accurate solution for characterizing unknown proteins. This approach has broad applications in biopharmaceuticals, antibody engineering, post-translational modification (PTM) analysis, and protein mutation studies. For example, in antibody drug development, precise sequence determination of the antibody variable region is essential. De novo sequencing facilitates the reconstruction of complete heavy and light chain sequences, ensuring proper antibody expression and function. Additionally, in biomedical research, many disease-associated proteins exhibit unknown PTMs or mutations, and de novo sequencing provides high-confidence sequence information, uncovering their potential biological significance. This method is also widely used in food science, industrial enzyme engineering, and pathogen identification, enabling the reliable characterization of unknown proteins and peptides.
The core principle of Peaks de novo sequencing involves high-resolution tandem mass spectrometry (MS/MS) data processing, coupled with advanced computational algorithms for peptide sequence inference. In a typical workflow, protein samples are enzymatically digested (e.g., with trypsin, Glu-C, or Lys-C) to generate peptides, followed by liquid chromatography-tandem mass spectrometry (LC-MS/MS) to obtain fragment ion spectra. Key analytical steps include high-quality data preprocessing, ion fragmentation pattern matching, sequence reconstruction, error correction with confidence scoring, and peptide sequence validation. Peaks employs sophisticated algorithms to enhance sequence interpretation accuracy and coverage, enabling researchers to derive comprehensive and precise amino acid sequences.
Compared to traditional database search methods, Peaks de novo sequencing offers several distinct advantages. First, it operates independently of protein sequence databases, making it particularly well-suited for identifying novel proteins, characterizing non-model organisms, and sequencing antibody regions-overcoming the limitations of database-dependent approaches. Second, its high accuracy, driven by advanced algorithmic processing and high-resolution mass spectrometry data, enhances sequence confidence while minimizing false identifications. Additionally, this method provides a more comprehensive analysis by not only determining amino acid sequences but also facilitating PTM identification and mutation analysis, leading to deeper biological insights. Furthermore, it is highly applicable to complex biological samples, allowing for the characterization of mixed protein samples, modified proteins, and low-abundance peptides, making it an essential tool in proteomics and biomedical research.
With extensive expertise in proteomics, MtoZ Biolabs offers high-precision de novo sequencing services. Our expert team integrates state-of-the-art mass spectrometry technologies to accurately determine protein amino acid sequences, ensuring high data reliability and reproducibility.
MtoZ Biolabs, an integrated chromatography and mass spectrometry (MS) services provider.
Related Services
How to order?
